Skip to main content
editor@theusajournals.com | Oscar Publishing Services Journal Home

American Journal Of Biomedical Science & Pharmaceutical Innovation

Peer Reviewed | Open Access | E-ISSN: 2771-2753
Published Article

Marketing Analysis of Hepatoprotective Drugs

Marketing Analysis of Hepatoprotective Drugs

  • Hasanova D.O.
    Tashkent Pharmaceutical Institute, Tashkent, Republic of Uzbekistan
  • Turdiyeva Z.V.
    Tashkent Pharmaceutical Institute, Tashkent, Republic of Uzbekistan
  • R.R.Maxmudov
    Academy of Sciences of the Republic of Uzbekistan, Institute of Bioorganic Chemistry, Tashkent, Republic of Uzbekistan
Hepatoprotector hepatobiliary State Register

This article provides a marketing analysis of the assortment of hepatoprotective drugs based on data from the 2023–2025 State Register of medicinal products, medical devices, and medical equipment approved for use in the Republic of Uzbekistan. During the study, using data from "Drug audit," the assortment range and market dynamics of hepatoprotective drugs produced by foreign and domestic pharmaceutical companies registered in the republic were examined. Additionally, the growth trends, competitive environment, and position in the pharmaceutical market of this group of drugs were assessed.

Маматисакова Гулчехра Алимджановна, Тухтаева Азиза Маджитовна, Алиева Рано Амануллаевна. Маркетинговый анализ лекарственных средств, применяемых при вирусном гепатите в Республике Узбекистан. Universum: медицина и фармакология : электрон. научн. журн. 2021. 6(78).

O‘zbekiston Respublikasi Prezidentining 2025-yil 28-yanvardagi PF-13-sonli “Farmatsevtika tarmog‘ini jadal rivojlantirishga oid qo‘shimcha chora-tadbirlar to‘g‘risida”gi Farmoni.

Dementia. World Health Organization. URL: https://www. who.int/health-topics/dementia#tab=tab_1 (дата обращения: 04.06.2024).

Vahidova N.M., Maksudova F.X., Safarova D.T., Sadikova G.E. O’zbekiston Respublikasida ro’yhatga olingan gipotenziv dori vositalarining marketing tahlili. Farmatsiya jurnali, №5, 2024. B.4-10.

Sharipova S.T., Jumayev A.A. Gepatopretektor ta’sirga ega bo’lgan dori vositalari assortimentining kontent tahlili. Farmatsiya jurnali, №5, 2024. B.24-29.

O‘zbekiston Respublikasida qo‘llashga ruxsat etilgan dori vositalar, tibbiy buyumlar va tibbiy texnika Davlat reestrining 2020-yildagi 24-soni, 2021-yildagi 25-soni, 2022-yildagi 26-soni, 2023-yildagi 27-soni, 2024-yildagi 28-soni.

Karayeva Nargizaxon Yuldash qizi, Turdieva Zilola Vahabjanovna, Abdullajonova Nodira G‘ulomjonovna. Neyroprotektor ta’sirga ega bo‘lgan dori vositalarining marketing tahlili // Farmatsiya ilmiy-amaliy jurnali, 2025.

O‘zbekiston Respublikasida qo‘llashga ruxsat etilgan dori vositalar, tibbiy buyumlar va tibbiy texnika Davlat reestrining 2023-2025-yillar nashri

European Association for the Study of the Liver (EASL). Clinical Practice Guidelines: Drug-induced liver injury // Journal of Hepatology. 2019. Vol. 70, Issue 6. P. 1222-1261.

Abduganiyeva Sh.A. Farmatsevtika bozorida dori vositalari marketingi va raqobatbardoshligini oshirish strategiyalari // ZiyoNET ilmiy kutubxonasi.